Publicacións (272) Publicacións de Javier Diez Domingo

2024

  1. Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection

    Journal of Infectious Diseases, Vol. 229, pp. S100-S111

  2. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

    Eurosurveillance, Vol. 29, Núm. 6

  3. Effectiveness of self-financed rotavirus vaccines on acute gastroenteritis primary care episodes using real-world data in Spain: a propensity score–matched analysis of cohort study

    European Journal of Pediatrics

  4. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

2023

  1. Addressing influenza’s underestimated burden – Iberian experts call to action

    BMC Infectious Diseases

  2. Adverse events in pregnant women with the tetravalent influenza vaccine obtained from cell cultures

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 420-422

  3. Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network

    Open Forum Infectious Diseases

  4. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

    Vaccine, Vol. 41, Núm. 1, pp. 251-262

  5. Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform

    Frontiers in Public Health, Vol. 11

  6. Bronchiolitis, Regardless of Its Etiology and Severity, Is Associated With Increased Risk of Asthma: A Population-Based Study

    The Journal of infectious diseases, Vol. 228, Núm. 7, pp. 840-850

  7. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis

    The Lancet Infectious Diseases

  8. Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015–2018

    BMC Infectious Diseases, Vol. 23, Núm. 1

  9. Co-creation of information materials within the assent process: From theory to practice

    Health Expectations, Vol. 26, Núm. 1, pp. 429-439

  10. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant

    Journal of Medical Virology, Vol. 95, Núm. 1

  11. Excess hospitalizations and mortality associated with seasonal influenza in Spain, 2008–2018

    BMC Infectious Diseases, Vol. 23, Núm. 1

  12. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

    The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302

2022

  1. A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018–19 season: the Gripómetro

    BMC Public Health, Vol. 22, Núm. 1

  2. Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain

    BMC Public Health, Vol. 22, Núm. 1

  3. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study

    BMC Infectious Diseases, Vol. 22, Núm. 1

  4. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

    The Lancet, Vol. 399, Núm. 10340, pp. 2047-2064